(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 29.67%64.2B | 48.96%33.19B | 145.63%113.74B | 138.60%85.54B | 155.82%49.51B | 75.92%22.28B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B |
Operating income | 29.67%64.2B | 48.96%33.19B | 145.63%113.74B | 138.60%85.54B | 155.82%49.51B | 75.92%22.28B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B |
Operating expenses | -30.90%-31.68B | -43.73%-80.96B | -26.10%-24.2B | 5.23%-56.33B | -7.63%-19.2B | |||||
Gross profit | 178.33%1.51B | 122.34%4.58B | 70.54%-1.92B | -195.14%-20.48B | -47.07%-6.53B | |||||
Selling expenses | -40.00%-1.88B | -56.18%-1.37B | -249.46%-2.93B | -86.61%-3.11B | -335.06%-1.34B | -57.76%-874M | 25.62%-839M | 28.11%-1.67B | 60.16%-308M | 18.05%-554M |
Administrative expenses | ---- | -7.96%-854M | ---- | 5.47%-2.44B | ---- | 1.62%-791M | ---- | -2.06%-2.58B | ---- | -13.88%-804M |
Research and development expenses | ---- | 11.49%-77M | ---- | -5.83%-218M | ---- | -16.00%-87M | ---- | -7.29%-206M | ---- | -70.45%-75M |
Profit from asset sales | ---- | 140.00%12M | ---- | -25.00%9M | ---- | -58.33%5M | ---- | --12M | ---- | 1,300.00%12M |
Employee expense | -14.84%-12.62B | ---- | -15.27%-23.61B | ---- | -13.98%-10.99B | ---- | 2.73%-20.49B | ---- | 9.90%-9.65B | ---- |
Depreciation and amortization | -8.04%-13.2B | ---- | -14.73%-25.02B | ---- | -14.68%-12.22B | ---- | 3.99%-21.81B | ---- | 4.98%-10.66B | ---- |
Revaluation surplus | ---- | 600.00%5M | 41.67%-7M | 86.67%-2M | ---- | 80.00%-1M | -9.09%-12M | -114.29%-15M | -300.00%-6M | -141.67%-5M |
-Changes in the fair value of financial assets | ---- | ---- | 41.67%-7M | ---- | ---- | ---- | -9.09%-12M | ---- | -300.00%-6M | ---- |
-Changes in the fair value of other assets | ---- | 600.00%5M | ---- | 86.67%-2M | ---- | 80.00%-1M | ---- | -114.29%-15M | ---- | -141.67%-5M |
Impairment and provision | 29.55%-31M | --0 | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 |
-Other impairment is provision | 29.55%-31M | --0 | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 |
Special items of operating profit | -32.55%-36.43B | 50.49%1.39B | -84.90%-64.01B | 63.85%3.83B | -90.22%-27.48B | 9.62%923M | 2.96%-34.62B | -38.34%2.34B | 17.40%-14.45B | -39.21%842M |
Operating profit | 101.56%40M | 119.37%544M | 93.92%-1.92B | 110.47%2.38B | 83.67%-2.57B | 60.68%-2.81B | -133.67%-31.59B | -171.63%-22.73B | -187.16%-15.72B | -58.44%-7.14B |
Financing income | -72.44%78M | ---- | -3.32%495M | ---- | 34.76%283M | ---- | -73.85%512M | ---- | -77.89%210M | ---- |
Financing cost | 33.92%-3.09B | -16.16%-1.42B | 20.96%-6.98B | 23.15%-5.62B | -4.64%-4.67B | -4.55%-1.22B | -51.98%-8.83B | -125.94%-7.31B | -61.17%-4.47B | -4.29%-1.17B |
Share of profits of associates | 955.56%95M | ---- | 174.19%115M | ---- | 28.57%9M | ---- | -59.79%-155M | ---- | -69.57%7M | ---- |
Share of profit from joint venture company | 525.00%34M | ---- | 126.00%13M | ---- | 73.33%-8M | ---- | -13.64%-50M | ---- | -233.33%-30M | ---- |
Special items of earning before tax | ---- | 229.41%56M | ---- | 72.28%174M | ---- | -68.52%17M | ---- | -30.82%101M | ---- | 63.64%54M |
Earning before tax | 59.16%-2.84B | 79.65%-816M | 79.36%-8.28B | 89.77%-3.06B | 65.21%-6.96B | 51.41%-4.01B | -129.05%-40.11B | -161.31%-29.94B | -174.66%-20B | -47.59%-8.25B |
Tax | -169.35%-258M | -342.31%-115M | -237.70%-336M | 6,928.57%492M | 1,671.43%372M | -62.50%-26M | -94.23%244M | -99.76%7M | -98.88%21M | -101.08%-16M |
After-tax profit from continuing operations | 52.93%-3.1B | 76.93%-931M | 78.39%-8.61B | 91.41%-2.57B | 67.04%-6.58B | 51.19%-4.04B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B |
After-tax profit from non-continuing business | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 |
Earning after tax | 52.93%-3.1B | 76.93%-931M | 78.39%-8.61B | 91.41%-2.57B | 67.04%-6.58B | 51.19%-4.04B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B |
Minority profit | -1.53%-331M | 34.69%-128M | 82.26%-446M | 102.04%37M | 73.67%-326M | 61.49%-196M | -134.95%-2.51B | -334.93%-1.82B | -551.58%-1.24B | -65.26%-509M |
Profit attributable to shareholders | 55.77%-2.77B | 79.09%-803M | 78.13%-8.17B | 90.73%-2.61B | 66.60%-6.26B | 50.52%-3.84B | -205.85%-37.36B | -244.47%-28.12B | -259.75%-18.74B | -103.94%-7.76B |
Basic earnings per share | 57.14%-0.12 | 76.47%-0.04 | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 |
Diluted earnings per share | 57.14%-0.12 | 76.47%-0.04 | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data